4.29 USD
↘ 0.00 (0.12%)PRE MARKET (AS OF 04:10 AM EDT)
X4 Pharmaceuticals, Inc. Common Stock
XFORNASDAQ • USD
Market: OPEN
Shares of X4 Pharmaceuticals, Inc. Common Stock (XFOR) are trading at $4.29. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, XFOR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Aug 13, 2026.
Open?$4.29
High?$4.29
Low?$4.29
Prev. Close?$4.29
Volume?11
Avg. Volume?672.4K
VWAP?$4.29
Rel. Volume?0.00x
Bid / Ask
Bid?$3.66 × 100
Ask?$4.91 × 100
Spread?$1.25
Midpoint?$4.29
Valuation & Ratios
Market Cap?425.3M
Shares Out?94.3M
Float?88.8M
Float %?94.2%
P/E Ratio?N/A
P/B Ratio?2.74
EPS?-$0.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
Employees
45
Market Cap
425.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2017-11-16
Address
61 NORTH BEACON STREET
BOSTON, MA 02134
Phone: 857-529-8300
BOSTON, MA 02134
Phone: 857-529-8300
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?1
Momentum?97
Short Sent.?43
Piotroski F-Score?3/9Weak
Altman Z-Score?-1.01Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?8.22%Elevated
Short Interest?7.3M
Days to Cover?12.8
Free Float88.8M
Avg Daily Volume572.8K
Settlement Date2026-07-31
Financial Health
Current Ratio?11.30Strong
Quick Ratio?11.02Strong
Cash Ratio?10.07Strong
Debt/Equity?0.49Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.74CHEAP▾
Peers100
S&P60
P/S?26.84HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.6CHEAP▾
S&P97
EV/Sales?19.37HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-58.0%WEAK▾
S&P3
ROA?-35.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$307.0M
Fundamentals ratios updated end of day